AbbVie announced that the Food and Drug Administration (FDA) has approved Humira (adalimumab) for the treatment of non-infectious intermediate, posterior, and panuveitis. This approval marks the first ...

MONTREAL, Feb. 20, 2019 /CNW/ - AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that Health Canada has approved HUMIRA® (adalimumab) for the treatment of ...

HUMIRA (adalimumab) 40mg/0.8mL solution for SC inj by AbbVie Abbott announced that the FDA has approved Humira (adalimumab) for inducing and sustaining clinical remission in adult patients with ...

HUMIRA is also indicated for the treatment of severe, active and progressive rheumatoid arthritis in adults not previously treated with methotrexate. HUMIRA can be given as monotherapy in case of ...

Abbott's HUMIRA® Approved In The European Union For The Treatment Of Crohn's Disease Abbott announced today that it has received marketing authorization from the European Commission for the use of ...

After 2 years of follow-up, many patients with axial spondyloarthritis who received early treatment with Humira were found to have low disease activity or be in remission, according to the results of ...

You might call it the Swiss army knife of pharmaceutical drugs. Since it hit the market in 2002 to treat rheumatoid arthritis, Humira has racked up one governmental approval after another to treat ...

- HUMIRA is now indicated to treat adult patients with moderate to severe ulcerative colitis who have had an inadequate response to immunosuppressants ABBOTT PARK, Ill., Sept. 28, 2012 /PRNewswire/ -- ...

Proactive therapeutic drug monitoring with Humira could help reduce the risk for treatment failure in patients with inflammatory bowel disease, according to results of a retrospective cohort. Adam S.

The arthritis drug Humira has been a blockbuster seller for more than two decades. Now some copycats could end Humira's reign. The blockbuster drug Humira has been one of the world's top sellers for ...

The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign. The blockbuster drug Humira has been one of the world's top sellers for ...

VIRGINIA--(BUSINESS WIRE)--Alvotech today filed a federal lawsuit (Case 1:21-cv-00589) seeking to end the monopoly that pharmaceutical giant AbbVie has long-maintained on the adalimumab market, sold ...